chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial and follow-up info has been received regarding a case in litigation concerning a male child who injected with vaccinations containing the toxic mercury-based preservative thimerosal. It was reported that on 02/19/1997, the pt was vaccinated with dose #1 of hep B vaccine recombinant, dose #2 was given on 04/10/1997 and dose #3 was given on 09/04/1997. Suspect concomitant therapy included one dose of MMR II given on 12/22/1997; ActHIB dose #1 given on 06/19/1997 and dose #2 given on 04/01/1998; HibTITER dose #1 given on 02/14/1997 and dose #2 given on 04/10/1998; alum. potassium/diphtheria toxoid/pertussis vaccine/tetanus toxoid (Tripedia) dose #1 given on 06/19/1997 and dose #2 given on 07/02/1998; varicella vaccine one dose given on 12/22/1997; and Orimune dose #1 given on 02/19/1997, dose #2 given on 04/12/1997, and dose #2 given on 06/19/1997. It is alleged that as a result of receiving vaccines containing the toxic mercury based preservative, thimerosal the pt suffers from and in the future will continue to suffer from the toxic neurological effects of mercury poisoning. It was also reported that the pt's brother suffered a similar experience (WAES0202USA00747). Upon internal review, mercury poisoning and neurological disorders were considered to be other important medical events. No further info is available.
Yesterday, September 18, 2017, on the advice of my doctors, I had a PNEUMOVAX 23 injection in my left (non-dominant) arm. I was told there could be some discomfort for several days, and, in fact, the person who gave me the injection said he had been in pain for 2 weeks. I have a very high pain threshold and rarely take any type of painkiller. However, I was totally unprepared for how painful and disabling this injection would be. By the evening, I could barely use my arm. I had to take painkillers to sleep at all, and by six this morning, I was wide awake because of the pain. If this vaccine is going to stay on the market, I think it should be accompanied by a warning that the patient may be disabled for several days after the injection. My experience is not at all unique. The internet has a site for evaluating drugs like PNEUMOVAX, and all of the comments mentioned severe injection site pain lasting at least several days.
Given vaccine on 3/18 in the left arm, then on the April 11th, a lump had a 2.5cm in size and arm and it was very sore. Improving and now smaller in size and not as painful.  Then had the second dose on 4/15 on the right arm and a rash started 2 days after injection (lasted 1-2 days), had 1cm size lumps under the right arm and right chest that went away.
26 year old female received influenza vaccination. Had some erythema in diffuse pattern to right upper arm extending from deltoid to 3-4 inches above her elbow. No SOB or wheezing. NKA. No PMHx for any significant medical concerns.
Red, splotchy rash on torso, back, scrotum, and buttocks.
Approx 5-10 min after receiving vaccines, pt became pale in the face & had near-syncope. He laid down approximately 10 min and was fine.
Pt recvd 3 doses of Engerix-B vax 30OCT90, 26NOV90 & 30APR91 & 9OCT91 it was determined that pts titer was neg p/3 doses of Engerix-B;
03/26/23 presents to  ED for "cough". PMHx of "hypertension, lung nodule and idiopathic pulmonary fibrosis on 2L oxygen at home"
No additional AE reported; A dose of GARDASIL 9 that experienced a temperature excursion was administered to a patient on 9 AUG 2021.; This spontaneous repot was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patent's medical history, concurrent conditions or concomitant medications was provided.  On 09-AUG-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter, lot # T029522 was confirmed to be valid, expiration date 13-MAR-2023, (route and site of administration were not reported) for prophylaxis.  The administered dose was exposed to the temperature of -4.8 degrees Celsius for 20 minutes. It was reported that there was no previous temperature excursion. No additional adverse event was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T029522; expirationdate: 13-MAR-2023; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
10 days after receiving the vaccine, the injection site became extremely swollen, red, and hard ? like a lump.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ACNE (acne on her face), MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause) and FATIGUE (tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired). On 18-Mar-2021, the patient experienced ACNE (acne on her face). On 19-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause). On 13-Mar-2021, PAIN IN EXTREMITY (sore arm) and FATIGUE (tired) had resolved. On 19-Mar-2021, ACNE (acne on her face) had resolved. On 02-Apr-2021, MENSTRUATION IRREGULAR (she started her period after 7 years of being in menopause) had resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy: normal (normal) came back normal. On an unknown date, Computerised tomogram: abnormal (abnormal) thickened uterine wall consistent with menstruation. On an unknown date, Ultrasound scan: abnormal (abnormal) Thickened uterine wall consistent with menstruation. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant medications were not provided. Treatment information was not provided by reporter. This case was linked to MOD-2021-074747.
I'm sick now; Major headache; Body aches; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I'm sick now), HEADACHE (Major headache), MYALGIA (Body aches) and CHILLS (Chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (I'm sick now), HEADACHE (Major headache), MYALGIA (Body aches) and CHILLS (Chills). At the time of the report, ILLNESS (I'm sick now), HEADACHE (Major headache), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.            Concomitant product use was not provided. Treatment information was not provided.    Reporter did not allow further contact
ACUTE NON ST ELEVATION MI HYPOTENSION ACUTE HYPOXEMIC RESPIRATORY FAILURE 2/6/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Tinnitus. Started and is still persisting and now non-stop. Have tried multiple treatments with ENT as well as attenuation therapy.
side effects of the moderna covid vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects of the moderna covid vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects of the moderna covid vaccine). At the time of the report, VACCINATION COMPLICATION (side effects of the moderna covid vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
The patient reports on November 26, she developed hives and started on her ears then moved to her neck.  She treated them with hydrocortisone.  However the next day she had similar symptoms that expanded to involve her back.  She was seen at her at a wrap where she works and was prescribed methylprednisolone, Allegra, and diphenhydramine.  These helped considerably with the hives.  However she stopped all these medications on December 3.  After stopping these medications she had a very prominent flare of her hives and has continued to have hives since that time.
Pt c/o shortness of breath over night. Noticed swelling on the left arm. No rxn, fever was noted and neg vomiting- vaccine was given 2 days before.
Firm, red nodule warm touch and about 4 finger lengths. Big at an orange. Happened about 7 or 8 hours after immunization. Patient took TYLENOL and BENADRYL after calling pharmacy.
First dose: Started losing voice; First dose: The next day felt like had the flu; First dose: Arm started hurting; It is a hoarse voice; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number: EW0176), via an unspecified route of administration, administered in Right upper arm on 28Apr2021 (appointment at 12:20) as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient never had allergies. Patient received first dose Pfizer Covid Vaccine earlier this month. On 28Apr2021, patient's arm was sore for a few days which she had noticed on the second day after receiving the first dose Pfizer Covid Vaccine. The next day on 29Apr2021, the patient felt like flu (not stomach flu) which didn't last long, just like a day or two. More like an achy and pain and kind of headache. Patient was losing voice on 30Apr2021. Patient had contributed this to being lethargic from receiving the Pfizer Covid Vaccine, thought it was par for the course. It was a hoarse voice, but the patient had to work to get it out. Patient got her lungs listened by a nurse a couple days ago, and lungs seemed to sound good. Outcome of the events "first dose: the next day felt like had the flu, it is a hoarse voice and first dose: arm started hurting" was unknown, while for event "first dose: started losing voice" was not recovered.
severe headache present from 9/21 to present. Reported headache to Rheumatologist who increase Predinisone to 10mg dose from 8mg. Headache persisted and became more intense by October 12 leading to an Emergency room visit after feeling dizziness headache and blood pressure reading of 188/90. (usual reading 146/70) Evaluated in the Hospital and then admitted for treatment and observation. By October 13, blood pressure was lowered enough to be discharged. Headache improved but still present with weakness and dizziness.and heart palpitations
Exactly  1 week later  arm swollen at injection  site  and it is warm to touch and itchy.   Just happened today 12012021
Pain, heat, redness & swelling in left arm.  Headache from 3:00 to 8 :00 p.m..  Woke the next day with arm still swollen and painful to the touch.
Headaches, with some chills, nausea, and body aches, recurring nightly, lasting through the morning, then clearing up during the day. Did not appear to have a fever or any other outward signs. This pattern lasted four nights and mornings. After the fourth morning no further symptoms appeared.
Began to throw up, looked like he was having a febrile seizure. Very weak like a rag doll flopping around in your arms. Lethargic, unresponsive loss of color to face. Took to Urgent care right away, then to ER.
Initial information received on 15-Oct-2018 regarding an unsolicited valid non-serious case received from a non-healthcare professional. This case involves a 24 years old female patient who experienced rash around the injection site that had moved down her arm, while she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 01-Oct-2018, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UI997AA via intramuscular route in the left deltoid. The patient developed a non-serious rash around the injection site that had moved down her arm (rash generalised), on the same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. It was reported that she had experienced these symptoms for the past two weeks. Relevant tests were not reported. Final diagnosis was rash around the injection site that had moved down her arm. Medical care sought on 15-Oct-2018 and Cortisone Cream 1% prescribed to be used daily. The outcome of the event was not reported. Documents held by sender: none.
hadn't received the 2nd dose yet; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete course of vaccination in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in September 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: hadn't received the 2nd dose yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 10-MAY-2023 The vaccine administration facility was the same as primary reporter. VAERS details were reported for 1st dose. The reporter consented to follow up. Till the time for reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination.
Arm/shoulder pain, painful to move arm.  had normal reactions after vaccination (flu like symptoms), but arm pain persisted
Severe abdominal cramping this lasted for 5 days. More severe the first 3 days and slowly less severe over the last two days. Not hungry during this time and no bowel movements. Felt pressure like he needed to go, but couldn't (he has never had abdominal pain or this before) His stomach hurt to the touch. He slept for two days and couldn't eat any food. No vomiting or diarrhea just not hungry due to abdominal pain. He was home on the couch for 5 days.
Rash bil forearms, slightly raised small bumps, no itching but rash feels hot to touch. Also has same rash on left side of neck.
WBC 19,000; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A 67 year-old female patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Batch/Lot number: unknown) at the age of 67 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for Covid-19 immunisation. The following information was reported: WHITE BLOOD CELL COUNT INCREASED (non-serious) with onset 31Mar2021, outcome "unknown", described as "WBC 19,000". The event "wbc 19,000" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The reporter stated his mom was in her early 70s and her and his father got their second dose on Monday. Stated his mom had follow up blood work done yesterday and her white blood cell count was 19,000. Stated he was curious if this was common for someone that got the second dose of the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 11/18/2021 I received my Covid-19 vaccine. On 10/14/2022 I began to feel tired with a tightness in my chest. I decided to take my blood pressure which was 200/120. I went to the emergency room and was tested with an EKG and stress test. I was diagnosed with Atrial fibrillation. I was admitted to the hospital for 2 days and then released. I had to take off work for 1 week for rest.
The same day of vax, the pt developed a fever for 24 hours. It was also noted that the pt would not calm down for several hours and was crying for 24 hours. Additionally, the pt vomited X two bottles. No injection site reaction was noted. An ER /doctor visit was required. It was reported that the pt was fine after her fever abated. The pt recovered by the next day. It was noted that the pt had a similar experience following exposure to haemophilus b conjugate vaccine. Additionally, it was reported that another pt had an adverse experience following exposure to haemophilus b conjugate vaccine + hepatitis b vaccine recombinant (yeast).
1st in October 2021, haven't had the 2nd; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in October 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 19-SEP-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient have not had the 2nd dose of Shingrix. The patient had asked if it was ok to get it now. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow up would not possible as no contact details were available.
sudden heat in chest, slow gradual swelling of tongue & throat, extreme nervousness, took 1 tsp DPH felt better;
Initial report was reported by healthcare professional on 03-Dec-2013: A 18 year old female, medical history and concomitant medication were unknown, received dose of FLUZONE at unknown anatomical site intramuscular in 2012. Patient developed general malaise and progressed to hurting all over, shakes and burning sensation of her skin. Events were for lasted for one - two hour and resolved at the time of report. Documents held by sender: none.
Breakthrough COVID19 infection in vaccinated patient.  Hospitalized from 9/28/21-10/7/21 and then discharged home.
No additional AE reported; temperature excursion; This spontaneous report was received from an other health care professional and refers to a 7-month-old female patient.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 28-DEC-2022, the patient was vaccinated with the third dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, lot #1892784, expiration date: 03-DEC-2023, administered orally for prophylaxis (dose, strength was not provided) after a temperature excursion of 47.9 degrees Fahrenheit for 47 min which occurred on 01-DEC-2022 (product storage error).  The vaccine was available for evaluation. The vaccine was used according to the instruction leaflet. Trained health care professional was the operator of the vaccine. The patient was vaccinated at public health clinic/hospital and the vaccine was purchased with public funds. No additional adverse events details were reported (no adverse event).
Pain in my left arm with burning and tingling in left hand particularly the pinky and ring finger.
unsure whether got high dose or regular.  Low grade fever, weakness, diarrhea that was explosive, some nausea. but no vomiting.
Throat was sore; Allergies have been more frequently than before the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA6780) via an unspecified route of administration in the left arm on 17Jul2021 at 09:30 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. Medical history included allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. On 17Jul2021 at 12:00, the patient experienced "allergies have been more frequently than before the vaccine" and the day of vaccination the throat was sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events allergies have been more frequently than before the vaccine and throat was sore were resolving at the time of reporting.
Information has been received from a pharmacist concerning a 5 year old male with a peanut allergy who was vaccinated with a dose of MMR II. Subsequently the patient experienced hives and had difficulty breathing from an anaphylactic reaction. The patient was seen by a pediatrician. The patient was treated with diphenhydramine HCl (BENADRYL), epinephrine and methylprednisolone (SOLU-MEDROL). Subsequently, the patient recovered. It was noted that the patient was given a dose of DTaP at a later time and developed the same reactions. There was no product quality complaint. The pharmacist considered hives, difficulty breathing and anaphylactic reaction to be an other important medical events (epinephrine). Additional information has been requested.
From initial information received on 4/12/04 from a health care professional regarding an adverse event occurring in the USA, it was reported that a 37 year old female patient received her second dose of Rabies vaccine, lot number 1419 (lot number to be confirmed with the reporter), administered in the left deltoid on 2/16/04. Later that same day, the patient developed malaise and flu-like symptoms for two days. It was reported that the patient experienced the same symptoms after her first dose of Imovax rabies on 1/30/04. Reportedly the patient recovered from this experience.
pt slept until 1030PM when became irritable lt leg became swollen & hot & APAP given per mom;pt taken to MD office 7FEB97 no redness or fever present but pt irritable w/4cm area of swelling @ inj site;
Diagnosed with transverse myelitis, loss of sensation below waist, muscle weakness, leg spasms, nerve pain, fall risk, currently wheelchair bound. Over course of twelve months. Conventional treatments as well as some off-label MS treatments have been ineffective, resulting in loss of employment and financial distress.